Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH); Cancellation of Meeting, 48148 [2021-18455]
Download as PDF
48148
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2021–18454 Filed 8–26–21; 8:45 am]
Agency Forms Undergoing Paperwork
Reduction Act Review
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee for Dose
Reconstruction Reviews (SDRR),
National Institute for Occupational
Safety and Health (NIOSH);
Cancellation of Meeting
Notice is hereby given of a change in
the meeting of the Advisory Board on
Radiation and Worker Health (ABRWH),
Subcommittee for Dose Reconstruction
Reviews (SDRR); June 16, 2021, from
10:30 a.m. to 2:30 p.m., EDT, in the
original FRN. The teleconference
meeting was published in the Federal
Register on April 23, 2021, Volume 86,
Number 77, pages 21738–21739.
This meeting is being canceled in its
entirety.
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free 1(800) CDC–
INFO, Email: ocas@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–18455 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:52 Aug 26, 2021
Jkt 253001
[30Day–21–1061]
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Behavioral Risk
Factor Surveillance System (BRFSS), to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 12, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Behavioral Risk Factor Surveillance
System (BRFSS) (OMB Control No.
0920–1061, Exp. 3/31/2022)—
Revision—National Center for Chronic
Disease and Public Health Protection
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to
revise information collection activities
for the Behavioral Risk Factor
Surveillance System (BRFSS) for the
period of 2022–2024. The BRFSS is a
nationwide system of cross-sectional
surveys using random digit dialed
(RDD) samples administered by health
departments in states, territories, and
the District of Columbia (collectively
referred to here as States) in
collaboration with CDC. Traditionally
subject recruitment and interview have
been conducted by telephone. In 2022–
2024, the BRFSS will introduce the
option to allow participants to
voluntarily complete online surveys,
after telephone recruitment. The BRFSS
produces state-level information
primarily on health risk behaviors,
health conditions, and preventive health
practices that are associated with
chronic diseases, infectious diseases,
and injury. Designed to meet the data
needs of individual states and
territories, the CDC sponsors the BRFSS
information collection project under a
cooperative agreement with states and
territories. Under this partnership,
BRFSS state coordinators determine
questionnaire content with technical
and methodological assistance provided
by CDC. For most states and territories,
the BRFSS provides the only sources of
data amenable to state and local level
health and health risk indicator uses.
Over time, it has also developed into an
important data collection system that
federal agencies rely on for state and
local health information and to track
national health objectives such as
Healthy People.
CDC bases the BRFSS questionnaire
on modular design principles to
accommodate a variety of state-specific
needs within a common framework. All
participating states are required to
administer a standardized core
E:\FR\FM\27AUN1.SGM
27AUN1
Agencies
[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Page 48148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18455]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH),
Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute
for Occupational Safety and Health (NIOSH); Cancellation of Meeting
Notice is hereby given of a change in the meeting of the Advisory
Board on Radiation and Worker Health (ABRWH), Subcommittee for Dose
Reconstruction Reviews (SDRR); June 16, 2021, from 10:30 a.m. to 2:30
p.m., EDT, in the original FRN. The teleconference meeting was
published in the Federal Register on April 23, 2021, Volume 86, Number
77, pages 21738-21739.
This meeting is being canceled in its entirety.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Toll Free 1(800)
CDC-INFO, Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-18455 Filed 8-26-21; 8:45 am]
BILLING CODE 4163-18-P